Cytosurge AG
Kerda Keevend is an experienced scientist with a robust background in application development, research, and collaboration in the fields of chemistry and bioimaging. Currently serving as an Application Scientist at Cytosurge AG since January 2022, Kerda previously held positions at SuSoS AG as a Research and Development Scientist and at ETH Zürich as a Postdoctoral Researcher, where significant advancements were made in developing cathodoluminescence-based protein labels. Kerda's academic journey includes a PhD from ETH Zürich, where pioneering work on bioimaging methods was accomplished, and a Master of Science in Chemistry from the University of Tartu. Prior roles include a Chemist at Interchemie, a PhD student at Empa, and a Research Intern at EPFL, demonstrating a consistent focus on nanoparticle synthesis, functionalization, and characterization throughout a diverse professional career.
Cytosurge AG
Cytosurge AG, founded in 2009, is a biotechnology company that manufactures and distributes cutting-edge solutions based on its patented FluidFM® technology. At the heart of this technology are the hollow FluidFM Probes – the Micropipette, Nanopipette, and the Nanosyringe – specifically designed to offer a wide range of unique applications for single-cell manipulation in biology research. Cytosurge's current systems compatible with FluidFM probes include the FluidFM ADD-ON for AFM systems and the standalone semi-automated FluidFM OMNIUM system. Cytosurge's vision is to unlock novel cures by translating next-generation genetic designs into living cells, contributing to human well-being through advancements in single-cell technologies. As the partner of choice for precision gene engineering cell line manufacturing, Cytosurge enables next-generation biologic production and cell and gene therapy treatments, empowering people to live longer and healthier lives. Cytosurge implements advanced genetically engineered cell lines that bring next-generation therapies to fruition, bridging the gap between genetic design tools and the manufacturing of high-precision gene-engineered cell lines. With a unique single-cell workflow and dynamic gene expression analytics, Cytosurge manufactures advanced gene-engineered cell lines, empowering next-generation treatments to benefit human well-being.